Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 72789-301

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 72789-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789301 Label (72789301)

72789301 Label (72789301)
The label for Bupropion Hydrochloride extended-release tablets, 150 mg strength, contains 90 tablets per bottle. It is labeled by PD-Rx Pharmaceuticals, Inc. The label displays the NDC number 72789-301-90 and includes warnings not to take in combination with ZYBAN or other bupropion-containing medications, as well as instructions to not crush or chew the tablets. The label also features dosage designation spaces, lot number B23D19, and expiration date 11/2025.*
FDA Label Image

Wellbutrin Chemical Structure (Bupropion Structure)

Wellbutrin Chemical Structure (Bupropion Structure)
Chemical structure of bupropion hydrochloride showing its molecular components including a chlorophenyl ring and other functional groups, with the hydrochloride indicated as a separate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.